To be specific, they inhibit histone deacetylase (HDAC) and activate G-protein-coupled receptor 43/41 (GPR43/41, or named FFAR2/3) signaling pathways, effectively facilitating the activity of regulatory T cells (Tregs), thereby showing a protective effect against colitis in mouse models [57,58,59]. Here, FFAR2 is linked to colitis.